Systems and Methods for Risk Based Insulin Delivery Conversion

    公开(公告)号:US20220240848A1

    公开(公告)日:2022-08-04

    申请号:US17592137

    申请日:2022-02-03

    Applicant: Dexcom, Inc.

    Inventor: Stephen D. Patek

    Abstract: Systems and methods are provided for managing hyperglycemia and hypoglycemia by reconciling incoming data to provide safe and reliable control to range using automatic bolus determination wherein the rate of insulin delivery is dependent on the level of hyperglycemic risk or hypoglycemic risk. Additionally, some implementations are directed to converting insulin delivery into a rate based on glycemic risk.

    JOINT STATE ESTIMATION PREDICTION THAT EVALUATES DIFFERENCES IN PREDICTED VS. CORRESPONDING RECEIVED DATA

    公开(公告)号:US20210151141A1

    公开(公告)日:2021-05-20

    申请号:US17096763

    申请日:2020-11-12

    Applicant: Dexcom, Inc.

    Inventor: Stephen D. Patek

    Abstract: Systems and methods are provided for reconciling untrusted data of a subject using trusted data pertaining to the subject. Systems and methods are directed to evaluating differences in predicted data with respect to corresponding received data. Systems and methods estimate metabolic states from a combination of trusted and untrusted metabolic inputs, along with optionally using a personalized mathematical model with parameter optimization. Systems and methods provide for reconciled untrusted inputs with their measured impact of the glycemic signals that is consistent with a metabolic model. Estimation of future metabolic states for decision support and automated insulin dosing is enabled. Replay of scenarios with estimated or reconciled data is also provided.

Patent Agency Ranking